UNSPSC 41202045: Plasmodium species antigen detection assays

In this classification, Plasmodium species antigen detection assays are devices used in test to identify specific Plasmodium species antigen detection assays antibodies in serum. US FDA regulates Plasmodium species antigen detection assays under 21 CFR 866.3402 and under FDA product code OAX.

UNSPSC 41202045 Plasmodium species antigen detection assays is a Commodity code that in practice encompasses a much broader scope of infectious disease testing and screening than its nominal title suggests. State and local governments actually buy HIV, hepatitis, and syphilis diagnostic assays, reagents, instrumentation, and related laboratory testing services under this code—not malaria antigen detection alone. The recent opportunities show procurement of rapid HIV test kits, fourth-generation HIV/hepatitis/syphilis combination screening systems, Abbott-manufactured reagent kits and analyzer supplies, clinical diagnostic laboratory services including blood chemistry testing, forensic analysis of bodily fluid specimens, and offender drug screening with immunoassay confirmation methodologies. Issuing bodies include state health departments (Illinois Department of Public Health), county community supervision departments (Collin County, Texas), city public health programs (City of Austin), state correctional agencies (Texas Department of Criminal Justice), and higher education institutions (University of Houston). The code shows little consolidated procurement—issuing bodies are dispersed across different functional areas (public health disease surveillance, criminal justice offender management, employee health services) and purchase on varying cadences.

Activity is concentrated in Texas and Illinois, with recent solicitations from the Illinois Department of Public Health for fifth-year statewide HIV/hepatitis/syphilis screening contracts and emergency Abbott reagent procurements, Collin County Community Supervision and Corrections Department seeking offender drug screening services (RFP 2026-327, due July 23, 2026, estimated $600,000 over five years), and the City of Austin procuring rapid HIV test kits (IFB9100AAM1023, due July 17, 2026). The Texas Department of Criminal Justice issued a forensic analysis RFP (696-IG-26-P034, due May 13, 2026) for urine and feces stain identification with expert witness testimony. Illinois IDPH's Invitation for Bid 26482DPHOFCDIB50489 (due March 16, 2026) sought fully automated fourth-generation combination testing for Hepatitis B and C, HIV-1/HIV-2, and Syphilis across an estimated 30,500 annual tests. Several Illinois procurements were executed as sole-source emergency awards to Abbott Laboratories for proprietary reagents and maintenance services. This code shows active demand but fragmented sourcing—no single repeat buyer dominates, and opportunities cluster around episodic state health laboratory needs, county offender testing programs, and municipal public health supplies rather than consolidated or recurring state frameworks.